Ricardo Martin Vidal
Overview
Explore the profile of Ricardo Martin Vidal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Long Y, Dimde M, Adler J, Vidal R, Povolotsky T, Nickl P, et al.
ACS Appl Mater Interfaces
. 2024 Nov;
16(49):67504-67513.
PMID: 39582136
Mucus is the first defense barrier against viruses in the human immune system. Inspired by the mucus structure, we designed a highly sulfated hydrogel to bind viruses and prevent infection...
2.
Muhlemann B, Trimpert J, Walper F, Schmidt M, Jansen J, Schroeder S, et al.
Proc Natl Acad Sci U S A
. 2024 Jul;
121(32):e2310917121.
PMID: 39078681
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has developed substantial antigenic variability. As the majority of the population now has pre-existing immunity due to infection or vaccination, the use of...
3.
Adler J, Vidal R, Langner C, Vladimirova D, Abdelgawad A, Kunecova D, et al.
Nat Commun
. 2024 Feb;
15(1):995.
PMID: 38307868
The development of effective SARS-CoV-2 vaccines has been essential to control COVID-19, but significant challenges remain. One problem is intramuscular administration, which does not induce robust mucosal immune responses in...
4.
Adler J, Vidal R, Voss A, Kunder S, Nascimento M, Abdelgawad A, et al.
Mol Ther
. 2023 Jun;
31(8):2391-2407.
PMID: 37263272
Live attenuated vaccines (LAVs) administered via the mucosal route may offer better control of the COVID-19 pandemic than non-replicating vaccines injected intramuscularly. Conceptionally, LAVs have several advantages, including presentation of...
5.
Bej R, Nie C, Ludwig K, Ahmadi V, Trimpert J, Adler J, et al.
Angew Chem Int Ed Engl
. 2023 May;
62(29):e202304010.
PMID: 37130003
Mucins are the key component of the defensive mucus barrier. They are extended fibers of very high molecular weight with diverse biological functions depending strongly on their specific structural parameters....
6.
Nouailles G, Adler J, Pennitz P, Peidli S, Teixeira Alves L, Baumgardt M, et al.
Nat Microbiol
. 2023 Apr;
8(5):860-874.
PMID: 37012419
Vaccines play a critical role in combating the COVID-19 pandemic. Future control of the pandemic requires improved vaccines with high efficacy against newly emerging SARS-CoV-2 variants and the ability to...
7.
Los B, Preussner M, Eschke K, Vidal R, Abdelgawad A, Olofsson D, et al.
Nucleic Acids Res
. 2022 Jun;
50(12):6769-6785.
PMID: 35713540
Antiviral innate immunity represents the first defense against invading viruses and is key to control viral infections, including SARS-CoV-2. Body temperature is an omnipresent variable but was neglected when addressing...